Study on the Treatment With Water-filtered Infrared-A (wIRA) Radiation in Patients With Morphea and Sclerotic Graft-versus-host Disease
Key facts
- Who runs it
- Medical University of Graz
- Where
- Austria2 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Terminated
- People taking part
- 11 people enrolled
- Started
- 1 Jul 2021
- Ended
- 13 Feb 2024
- Type of study
- Interventional, 2 groups
- Treatments tested
- infrared-A (wIRA)
- Record updated
- 30 January 2025
- Why it stopped
- The study was prematurely terminated due to recruitment difficulties.
Who can take part
- Age
- 18 years to 80 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Morphea
- Sclerotic graft-versus-host disease (GVHD)
Who cannot take part
- Inability to cope with the treatment plan
- Pregnant or breastfeeding women and women of childbearing potential without effective contraception
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This is a prospective, intra-individual comparative study to evaluate the effectiveness of local-water filtered infrared-A (wIRA) irradiation (applied by Hydrosun® radiator 750 for radiation at the clinic, or Hydrosun® 575home for home treatment) in patients with morphea or sclerotic GVHD (Graft-versus-host Disease). The purpose of the study is to determine whether wIRA irradiation can reduce fibrotic skin alterations in circumscribed scleroderma (morphea) or chronic graft versus host disease. wIRA irradiation is applied for 30 minutes 3 times per week for 20 weeks to a diseased skin area and a lesional skin on contralateral body site remains untreated. A total of 22 patients (20 evaluable patients with an expected drop-out rate of 10%) are to be included in this study. Group A: 11 patients with plaque morphea Group B: 11 patients with sclerotic GVHD.
The 2 groups in the trial
- MorpheaOther group
Treatment: infrared-A (wIRA)
- Sclerotic graft-versus-host disease (GVHD)Other group
Treatment: infrared-A (wIRA)
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Pilot Study on the Treatment With Water-filtered Infrared-A (wIRA) Radiation in Patients With Morphea and Sclerotic Graft-versus-host Disease
- Record updated
- 30 January 2025